Highest-materiality recent filing
Somnigroup & Leggett & Platt merger clears HSR waiting period; close expected by year-end 2026
HSR waiting period for Somnigroup/Leggett & Platt merger expired June 3, 2026.
Somnigroup shareholders approve doubling authorized common shares to 1B
Authorized common shares increased from 500M to 1B; preferred unchanged at 10M.
Somnigroup Q1 net sales +12.3% to $1.8B, adj. EPS +20%; declares $0.17 dividend
Net sales $1,801.5M, +12.3% YoY; EPS $0.49 vs ($0.17) loss (+388%); adj. EPS $0.59 vs $0.49 (+20%).
Somnigroup Q1 2026 adjusted EPS $0.59; FY2026 guidance $3.00-$3.40; Leggett & Platt deal updated.
Q1 net sales $1.8B (+12.3% YoY), GAAP net income $104M vs. loss of $33M, adjusted EPS $0.59 vs. $0.49.
Somnigroup to acquire Leggett & Platt in all-stock deal valued at ~$2.5B
Transaction at 0.1455 Somnigroup shares per LEG share; LEG shareholders to own ≈9% of combined company.
Somnigroup to acquire Leggett & Platt in all-stock merger; exchange ratio 0.1455
Each LEG share converts to 0.1455 shares of SGI common stock; no cash consideration except for fractional shares.
Somnigroup Q4 sales up 55%, EPS up 65%; raises dividend 13% to $0.17/share
Q4 net sales $1,868.4M (+54.7% YoY); GAAP EPS $0.66 (+65%); adjusted EPS $0.72 (+20%).
Somnigroup reports Q4 sales up 55% YoY; FY2025 adj EPS $2.70; guides FY2026 adj EPS $3.00-$3.40
Q4 2025 net sales $1,868M (+54.7% YoY); GAAP EPS $0.66 (+65%); adj EPS $0.72 (+20%).
Somnigroup to discuss all-stock acquisition of Leggett & Platt at $12/share, 30% premium
Leggett & Platt board authorized discussions and signed NDA to facilitate due diligence with Somnigroup.
Somnigroup proposes to acquire Leggett & Platt for $12/share in all-stock deal with 30.3% premium
Proposed consideration: shares of SGI stock valued at $12.00 per LEG share, a 30.3% premium over 30-day average price.
Somnigroup reports record Q3: sales $2.12B (+63%), EPS $0.83 (+14%), raises guidance
Net sales $2.12B, +63% YoY, driven by $1.07B Mattress Firm sales and synergy execution.
Somnigroup Q3'25 adj. EPS $0.95; FY2025 outlook $2.60-$2.75; targets $4.85 adj. EPS by 2028
Q3 2025 net sales $2,123M (+63.3% YoY); GAAP EPS $0.83; adjusted EPS $0.95.
Somnigroup Q2 net sales up 53% to $1.88B; raises full-year guidance
Net sales $1,880.8M (+52.5% YoY), driven by inclusion of $948.8M Mattress Firm sales.
Somnigroup Q2 sales $1.88B (+52.5%); adj EPS $0.53 (-15.9%); FY25 adj EPS $2.40-2.70
Q2 2025 net sales $1.88B, up 52.5% YoY; GAAP net income $99M, down 6.7%.
Somnigroup extends CEO Scott Thompson's contract to Dec 2029 with $10M bonus and 1.2M options
Term extended from Dec 31, 2026 to Dec 31, 2029.
Somnigroup announces secondary offering of 15.4M shares at $62 by selling stockholder
Selling stockholder (IBEX Topco B.V. subsidiary) offering 15,376,743 shares of SGI common stock.
Somnigroup Q1 net sales up 35% to $1.6B, net loss $33M from acquisition costs
Net sales $1.60B, +35% YoY, driven by $593.7M Mattress Firm stub period sales (Feb 5 – Mar 31, 2025).
SomniGroup Q1 sales rise 35% to $1.6B; GAAP EPS -$0.17; FY25 adj EPS $2.30-$2.65
Q1 2025 net sales $1,604.7M (+34.9% YoY); GAAP net loss $33.1M, EPS -$0.17.
Steven H. Rusing appointed President of Mattress Firm with $1M signing bonus
Steven H. Rusing appointed President of Mattress Firm, effective March 10, 2025.
SomniGroup closes Mattress Firm acquisition; acquired co's FY24 revenue $3.9B, net income $73M
Mattress Firm FY24 net revenue $3,916.3M, down from $4,134.1M in FY23 (-5.3%).
Somnigroup Q4 adjusted EPS up 13% to $0.60; dividend raised 15%; Mattress Firm deal closed
Q4 net sales $1,207.9M (+3.2% YoY); GAAP EPS $0.40 (-7.0%), adjusted EPS $0.60 (+13.2%).
Somnigroup posts FY2024 adj EPS $2.55; guides FY2025 $2.60-$3.00; Mattress Firm closed
Q4 2024 net sales $1,207.9M (+3.2% YoY); adj EPS $0.60 (+13.2% YoY).
Tempur Sealy announces CEO change at Mattress Firm; Scott Thompson named interim CEO
John Eck resigns as Mattress Firm CEO; consulting agreement signed for smooth transition.
Tempur Sealy completes $5B acquisition of Mattress Firm; name change to Somnigroup
Total purchase price approx. $5B: $2.7B cash + 34.2M Tempur Sealy shares issued.
Tempur Sealy closes $5B acquisition of Mattress Firm; plans name change to Somnigroup
Total purchase price ~$5B: $2.7B cash plus 34.2M shares of Tempur Sealy common stock.
Tempur Sealy unveils Sealy Posturepedic 75th anniversary launch with record media investment
Sealy Posturepedic 75th anniversary in 2025; exclusive PrecisionFit coil tech; record media investment starts Memorial Day.
Tempur Sealy Q3 sales up 1.8% to $1.3B, EPS up 14% to $0.73; dividend $0.13
Net sales $1,300M (+1.8% YoY); North America -0.8%, International +12.4%.
Tempur Sealy updates 2024 outlook, reports Q3 results; Mattress Firm deal progressing
Q3 2024 net sales $1.30B (+1.8% YoY), GAAP EPS $0.73, adjusted EPS $0.82.
Term Loan B facility of $1.6 billion closed; matures October 24, 2031. Proceeds held in escrow for Mattress Firm acquisition.
Tempur Sealy sues FTC to halt administrative challenge to Mattress Firm merger
Filed complaint in Southern District of Texas seeking injunction against FTC's separate administrative proceeding.
Tempur Sealy prices $1.6B Term Loan B at SOFR+250 bps for Mattress Firm deal financing
Term Loan B priced at $1.6B aggregate principal, SOFR + 250 bps with OID of 99.5.
Tempur Sealy Updates on Mattress Firm Deal, Announces $1.6B Debt Facility and Divestiture Plan
Hearings for FTC challenge to acquisition set to begin November 12, 2024; transaction expected to close late 2024 or early 2025.
Tempur Sealy Q2 sales down 2.8% but EPS up 15.4%; dividend unchanged at $0.13
Net sales $1,233.6M (-2.8% YoY); North America -3.8%, International flat.
Tempur Sealy Q2 sales slip 2.8%; maintains FY24 adjusted EPS guidance $2.45–$2.65
Q2 net sales $1,233.6M (-2.8% YoY); adjusted EPS $0.63 (+8.6% YoY); net income $106.1M (+14.8%).
FTC challenges Tempur Sealy's Mattress Firm acquisition; company vows to litigate
FTC announced it will file complaint and seek preliminary injunction to block Tempur Sealy's proposed acquisition of Mattress Firm.
Tempur Sealy Q1 net sales $1.19B (-1.5%); adj. EPS $0.50; FY2024 guidance $2.60-$2.90
Q1 2024 net sales $1,189.4M (-1.5% YoY); net income $76.3M (-10.6%); adjusted EPS $0.50 (-5.7% YoY).
Tempur Sealy Q1 net sales $1.19B (-1.5% YoY), EPS $0.43 (-10.4%); declares $0.13 dividend
Net sales $1,189.4M, down 1.5% YoY; gross margin improved 170bps to 43.1%.
Q4 net sales $1,170.5M, down 1.4% YoY; North America -4.0%, International +7.8%.
It was determined that Mr. Scott Vollet, Executive Vice President, Global Operations of Tempur Sealy International, will no longer function as an executive officer or Section 16 insider for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
On March 4, 2025, the Board of Directors (the "Board") of Somnigroup International Inc. (the "Company") appointed Steven H. Rusing as President of Mattress Firm Group LLC (collectively with subsidiaries, "Mattress Firm"), effective March 10, 2025.
Pursuant to the terms of the Merger Agreement, the Board of Directors (the "Board") of the Company approved an increase of the size of the Board from 7 to 8 members effective February 5, 2025 and filled the newly created vacancy by appointing Peter R. Sachse, as an independent director, to serve on the Board, effective on the same day.
the Board of Directors (the "Board") of the Company approved an increase of the size of the Board from 7 to 8 members effective February 5, 2025 and filled the newly created vacancy by appointing Peter R. Sachse, as an independent director, to serve on the Board, effective on the same day.
Max materiality 1.00 · Median 0.72 · Most common event earnings